We still need to identify which patient populations will benefit the most for long-term health outcomes, especially if costs remain so high
Overall agreement 85%: A+ 65%, A 20%, A 10%, D 0%, D 5%, D+ 0%
SURMOUNT trials demonstrated ~22% body weight reduction vs ~15% for semaglutide at highest doses
MC3R / Peripheral Metabolic Modulation MT-2 also engages MC3R, expressed in peripheral tissues including adipose, gut, and immune cells
A 2025 meta-analysis of 21 studies concluded that low-to-moderate intensity exercise can elicit remarkable improvements for managing menopausal anxiety as well as depression
Using Wegovy or Zepbound for GLP-1 perimenopause weight loss can help overcome this hormonal hurdle and improve overall cardiovascular and metabolic health